Melanie Morel-Ferris
Geen lopende functies
Profiel
Melanie Morel-Ferris worked as a Corporate Controller at Astrodyne Corp.
from 2014 to 2016, an Associate Director-Accounting at ARIAD Pharmaceuticals, Inc. in 2014, and a Senior Director-Finance & Controller at Invivo Therapeutics Holdings Corp.
in 2017.
She obtained an undergraduate degree from Assumption College.
Eerdere bekende functies van Melanie Morel-Ferris
| Bedrijven | Functie | Einde |
|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Financieel Directeur/CFO | 29-03-2017 |
Astrodyne Corp.
 Astrodyne Corp. Electrical ProductsProducer Manufacturing Astrodyne Corp. manufactures switching power supply and converters. The firm’s products include power supplies and EMI filters for industrial, semiconductor manufacturing, medical, consumer appliance, military, and aerospace sectors. The company was founded in 1994 and is headquartered in Mansfield, MA. | Comptroller/Controller/Auditor | 01-05-2016 |
| ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-07-2014 |
Opleiding van Melanie Morel-Ferris
| Assumption College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Astrodyne Corp.
Astrodyne Corp. Electrical ProductsProducer Manufacturing Astrodyne Corp. manufactures switching power supply and converters. The firm’s products include power supplies and EMI filters for industrial, semiconductor manufacturing, medical, consumer appliance, military, and aerospace sectors. The company was founded in 1994 and is headquartered in Mansfield, MA. | Producer Manufacturing |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
